Meng H. is a Senior Principal Scientist and Group Lead at Genentech, where they have contributed to oncology biomarker development and translational medicine. They previously served as an Institute Scientist at MD Anderson Cancer Center and held research positions at Howard Hughes Medical Institute and in cancer genomics and epigenetics. Meng earned a Bachelor of Science in Biological Science and Biotechnology from Tsinghua University and a PhD in Pharmacology and Cancer Biology from Duke University. Their research has been published in prestigious journals, highlighting their expertise in the field.
This person is not in any teams
This person is not in any offices